Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DU125530 plus Fluoxetine in Major Depressive Disorder
NCT01119430Phase 2Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- May 2004
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DU-125530 in major depressive disorder (MDD), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started May 2004; status: terminated.
02
Drugs
DU-125530
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01119430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119430.